Morningstar

QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and GENCURIX, Inc. (KOSDAQ: 229000) today announced a new partnership to develop oncology assays for use on the QIAcuityDx platform, a ...
Morningstar

Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of four new Droplet Digital™ PCR (ddPCR™) ...

Is Bio-Rad’s Earnings Miss and Biodesix Partnership Redefining the Investment Outlook for BIO?

On October 29, 2025, Bio-Rad Laboratories reported third-quarter earnings with sales of US$653 million and a net loss of US$341.9 million, while also completing a major share repurchase and announcing ...
Pharmabiz

Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital PCR high complexity assays

Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital PCR high complexity assays: Louisville, Colorado Friday, October 24, 2025, 12:00 ...
Business Wire

Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced today that the company’s ...